Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hui Ye
Observed name:
Hui YE
Institutions:
Guangzhou Institute of Dermatology,
Guangzhou Medical University
Observed institutions:
Guangzhou Institute of Dermatology,
Guangzhou Medical University
ORCID:
0000-0003-2708-6150
Observed ORCID:
0000-0003-2708-6150
OpenAlex ID:
A5088287166
Abrocitinib Monotherapy for Refractory Prurigo Nodularis: Report of Two Successful Cases
2024
·
Jingyao Liang
, Wei Li
, et al.
·
Clinical Cosmetic and Investigational Dermatology
·
7
PDF
Combined Abrocitinib and Acitretin Therapy for Darier’s Disease: A Case Report
2024
·
Hui Ye
, Weifeng Chen
, et al.
·
Clinical Cosmetic and Investigational Dermatology
·
6
PDF
Spesolimab Treatment in GPP: Impact of IL-36RN Mutations and Concomitant Plaque Psoriasis
2025
·
Wei Li
, Jingyao Liang
, et al.
·
Clinical Cosmetic and Investigational Dermatology
·
4
Effectiveness and safety of age-based dosing of abrocitinib in children and adolescents with moderate to severe atopic dermatitis: A two-center, prospective real-world study in China
2025
·
Jingyao Liang
, Hui Ye
, et al.
·
Medicine
·
4
Fractional Carbon Dioxide Laser Combined with Secukinumab in the Treatment of Refractory Psoriasis Lesions on the Lower Legs
2024
·
Hui Ye
, Wei Li
, et al.
·
Clinical Cosmetic and Investigational Dermatology
·
1
PDF
Show more works
View as search
Works count:
6
Citation count:
23
H-index:
4
I10-index:
Year
Topic
Type